Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the Stanford Coronary Risk Intervention Project.
about
Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study.Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trialLDL particle heterogeneity, and its association with other established cardiovascular risk factors in a young Indian industrial populationCardiometabolic risk management in type 2 diabetes and obesity.Hepatic lipase as a focal point for the development and treatment of coronary artery disease.Identification and treatment of hypertriglyceridemia as a risk factor for coronary heart disease.Small, dense low-density lipoprotein subclass pattern B: issues for the clinician.Small LDL and its clinical importance as a new CAD risk factor: a female case study.New developments in atherosclerosis imaging: electron beam tomography.Targeting triglycerides as prognostic indicators and determining lowest values for patient benefit.Small, dense low-density lipoprotein: risk or myth?Genetics of LDL particle heterogeneity: from genetic epidemiology to DNA-based variations.Low-density lipoprotein particle number and risk for cardiovascular disease.Cardiovascular disease and diabetes: modifying risk factors other than glucose control.Sophisticated tests for susceptibility to atherosclerosis: an added value for heart hospitals.Low-density lipoprotein size and cardiovascular risk assessment.Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.The clinical relevance of low-density-lipoproteins size modulation by statins.Who needs to care about small, dense low-density lipoproteins?Significance of small dense low-density lipoprotein as a risk factor for coronary artery disease and acute coronary syndrome.The role of statin drugs in the management of the peripheral vascular patient.Is it LDL particle size or number that correlates with risk for cardiovascular disease?The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance?Should we measure routinely oxidised and atherogenic dense low-density lipoproteins in subjects with type 2 diabetes?Effects of rosuvastatin versus atorvastatin on small dense low-density lipoprotein: a meta-analysis of randomized trials.Ezetimibe alone or in combination with simvastatin increases small dense low-density lipoproteins in healthy men: a randomized trial.Post-statin approaches to hyperlipidaemia.Small, dense, low-density lipoprotein and atherosclerosis.Niacin treatment of the atherogenic lipid profile and Lp(a) in diabetes.Relative importance of different lipid risk factors for the development of myocardial infarction at a very young age (≤ 40 years of age).Atorvastatin reduces remnant lipoproteins and small, dense low-density lipoproteins regardless of the baseline lipid pattern.Relationship between smoking and dyslipidemia in western Chinese elderly males.Microchip-based small, dense low-density lipoproteins assay for coronary heart disease risk assessment.Effects of pioglitazone on lipid and lipoprotein profiles in patients with type 2 diabetes and dyslipidaemia after treatment conversion from rosiglitazone while continuing stable statin therapy.Hypercholesterolemia and Dyslipidemia: Issues for the Clinician.Hypercholesterolemia and Dyslipidemia.Low-density lipoprotein subclass distribution pattern and adiposity-associated dyslipidemia in postmenopausal women.Significance of small dense low-density lipoproteins as coronary risk factor in diabetic and non-diabetic Korean populations.Low-density lipoprotein particle diameter and mortality: the Ludwigshafen Risk and Cardiovascular Health Study
P2860
Q21262011-8637AE6C-F434-40A9-BDC3-60DE60D5152CQ28351795-7D5F21E9-8F62-4640-8A9D-2B5FCB188903Q28834654-92A51491-50E7-44D5-96C0-6A9B6E0828A6Q30446865-B4DE10F2-2D3B-47B9-ACDB-A4C9B51BD6ECQ32056551-E2444527-8BC9-49AF-BEAF-FA3C0560183AQ34027319-A4CDB0B6-B311-4714-BCEA-9659560519E2Q34107171-18768FBD-87BB-4774-981E-9D63CE4D818BQ34157888-C1E2ABB4-F665-4141-BE56-357496C5A1FAQ34327251-FECAAB5D-529B-47D1-B0B1-A384D56C3819Q34336868-5634017F-1DA3-4570-B84B-3EFF6C374AD8Q35058222-8988504C-BE3C-4DA6-BD76-E9B0108C378CQ35732509-C49F0E0F-54EF-4CB9-A04E-106F4632C837Q35856897-C9F091DC-B954-4612-940F-852A2C00210BQ36065465-32B3B31A-1F03-44F6-904D-E37D3DEEBEC2Q36091141-75366913-A970-496E-9D01-36F2064D9439Q36349994-9219184C-FF6A-4683-A87E-21169443B3F1Q36395720-15129A9A-DEFC-48A8-A840-EA0FECE85D09Q36455894-C4F79462-6D11-40AF-BE4D-A1780B6223B4Q36507342-48B5F95B-6F39-4833-AEDD-47BCD03873DCQ36970686-6F83595A-5524-49CB-BA5A-D9A53A84E29EQ37206847-8812DD1E-92B5-446D-BE3B-7FC400B49EACQ37214238-F5DCFF54-A93F-403C-803F-930E425048CCQ37244731-6982E2C9-211B-4748-A18C-EE11C669A94DQ37299798-01818F81-2C5C-40FA-A02F-5EF9D632E389Q37787320-364BFA67-F74F-4137-8C6D-3907E7D9CB14Q38104228-6D912F30-1DEC-4215-BAE3-0DF6566F3307Q38372936-55B9652C-CECB-4F21-BE2B-A23561B8E584Q40409025-B35ABCF6-2F2B-4CFB-983A-9F579A1CA8C6Q43921249-F6E57C00-DC72-44D2-ACD8-54A27E927079Q44051686-954CDC66-B5E1-4D23-94EB-7A298C595232Q45046990-6B6B60DA-C472-4113-8207-F295F23F1FF6Q45148210-5CB02B46-31F6-439B-876C-D592DBAF2A7BQ46592171-AF900564-DFF7-4F1D-8971-457758680053Q46668215-CB3E41F3-ACD1-4EBF-8596-66A480F852C7Q51496275-636ED394-F811-410F-88C2-F52AC4E88617Q51537186-FD2E966D-42D2-425B-ABF4-8B4121196C2AQ51552490-E99673D9-1E04-41F5-866D-6274C8145575Q51558198-6A90E6BB-B68A-40D9-B375-85C2A02CFFD3Q53621798-887C639E-FCE4-4E76-B782-A44D61B4A551Q57315961-AF28DF6A-15C1-4225-A5DD-83F80D472F07
P2860
Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the Stanford Coronary Risk Intervention Project.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Predominance of dense low-dens ...... ary Risk Intervention Project.
@en
Predominance of dense low-dens ...... ary Risk Intervention Project.
@nl
type
label
Predominance of dense low-dens ...... ary Risk Intervention Project.
@en
Predominance of dense low-dens ...... ary Risk Intervention Project.
@nl
prefLabel
Predominance of dense low-dens ...... ary Risk Intervention Project.
@en
Predominance of dense low-dens ...... ary Risk Intervention Project.
@nl
P2093
P356
P1433
P1476
Predominance of dense low-dens ...... ary Risk Intervention Project.
@en
P2093
P304
P356
10.1161/01.CIR.94.9.2146
P407
P577
1996-11-01T00:00:00Z